American Association for Cancer Research
Browse
crc-22-0356-s01.pdf (280.82 kB)

Supplementary Figure SF1 from Mouse IgG2a Isotype Therapeutic Antibodies Elicit Superior Tumor Growth Control Compared with mIgG1 or mIgE

Download (280.82 kB)
journal contribution
posted on 2023-04-04, 02:05 authored by Natasa Vukovic, Aina Segués, Shuyu Huang, Martin Waterfall, Alice J.A.M. Sijts, Dietmar M. Zaiss

Quality control of anti-Thy1.1 antibodies.

Funding

EC | Horizon 2020 Framework Programme (H2020)

History

ARTICLE ABSTRACT

Direct comparisons of different antibody isotypes of the same specificity in cancer settings are still scarce. Here, it is shown that mIgG2a has a greater effect compared with mIgG1 and mIgE in controlling tumor growth in a therapeutic setting.

Usage metrics

    Cancer Research Communications

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC